UNITEDHEALTH GROUP INC
Close on Oct 19, 2026
- Market cap
- $368.63B
- P/E (TTM)
- 26.2
- Dividend yield
- 2.15%
Earnings
Next report expected Oct 27, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Jul 16, 2026 | Before market open | $112.00B | $6.04 | $6.38 |
| Q1 FY2026 Ended Mar 31, 2026 | Apr 21, 2026 | Before market open | $111.70B | $6.90 | $7.23 |
| Q4 FY2025 Ended Dec 31, 2025 | Jan 27, 2026 | Before market open | $113.20B | $0.01 | $2.11 |
| Q3 FY2025 Ended Sep 30, 2025 | Oct 28, 2025 | Before market open | $113.20B | $2.59 | $2.92 |
| Q2 FY2025 Ended Jun 30, 2025 | Jul 29, 2025 | Before market open | – | – | – |
| Q1 FY2025 Ended Mar 31, 2025 | Apr 17, 2025 | Before market open | $109.60B | $6.85 | $7.20 |
| Q4 FY2024 Ended Dec 31, 2024 | Jan 16, 2025 | Before market open | $100.81B | $5.98 | $6.81 |
| Q3 FY2024 Ended Sep 30, 2024 | Oct 15, 2024 | Before market open | $100.80B | $6.51 | $7.15 |
| Q2 FY2024 Ended Jun 30, 2024 | Jul 16, 2024 | Before market open | $98.90B | $4.54 | $6.80 |
| Q1 FY2024 Ended Mar 31, 2024 | Apr 16, 2024 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Jan 12, 2024 | Before market open | – | – | – |
Company guidance
Outlook given with results on Jul 16, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted Earnings per Sharenon-GAAP | Full Year 2026 | $19.50 to $20.00 | Raised |
| Diluted Net Earnings per ShareGAAP | Full Year 2026 | $18.45 to $18.95 | Raised |
| Optum Operating EarningsGAAP | Full Year 2026 | $13.45B | Raised |
| UnitedHealthcare Adjusted Operating Earningsnon-GAAP | Full Year 2026 | $12.00B | New |
| Optum Health Adjusted Operating Earningsnon-GAAP | Full Year 2026 | $2.22B | Lowered |
| Optum Insight Adjusted Operating Earningsnon-GAAP | Full Year 2026 | $4.75B | Raised |
| Optum Rx Adjusted Operating Earningsnon-GAAP | Full Year 2026 | $6.25B | Raised |
| Optum Adjusted Operating Earningsnon-GAAP | Full Year 2026 | $13.22B | Raised |
| UnitedHealth Group Adjusted Operating Earningsnon-GAAP | Full Year 2026 | $25.22B | Raised |
| Optum Insight Operating EarningsGAAP | Full Year 2026 | $4.93B | Raised |
| Optum Rx Operating EarningsGAAP | Full Year 2026 | $6.25B | Raised |
| UnitedHealthcare Operating EarningsGAAP | Full Year 2026 | $12.00B | Lowered |
| Optum Health Operating EarningsGAAP | Full Year 2026 | $2.28B | Lowered |
| UnitedHealth Group Operating EarningsGAAP | Full Year 2026 | $25.45B | Raised |
| Tax Rate | Full Year 2026 | 18.5% | Lowered |
| Medical Care Ratio | Full Year 2026 | 88.1% | New |
| Cash Flows from Operations | Full Year 2026 | $24.00B | New |
| Share Repurchase | Full Year 2026 | $5.00B | Lowered |
| Net Earnings to UNH ShareholdersGAAP | Full Year 2026 | $16.75B | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Unitedhealth filed with the SEC
EX-99.1 to Form 8-K
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
EX-99.1 to Form 8-K
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
EX-99.1 to Form 8-K
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
EX-99.1 to Form 8-K
Results of operations · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · EX-99.2 to Form 8-K
UnitedHealth Group Reports Third Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
UnitedHealth Group Re-Establishes Full Year Outlook
Results of operations · EX-99.1 to Form 8-K
UnitedHealth Group Announces Leadership Transition
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
UnitedHealth Group Reports First Quarter 2025 Results
Results of operations · EX-99.1 to Form 8-K
UnitedHealth Group Reports 2024 Results
Results of operations · EX-99.1 to Form 8-K
UnitedHealth Group Statement on Today’s Events
Other events · EX-99.1 to Form 8-K
UnitedHealth Group Updates Business Outlook Ahead of Investor Conference
Regulation FD disclosure · EX-99.1 to Form 8-K
UnitedHealth Group to Host 2024 Investor Conference
Regulation FD disclosure · EX-99.1 to Form 8-K
UnitedHealth Group Reports Third Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
UnitedHealth Group Reports Second Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
UnitedHealth Group Reports First Quarter 2024 Results
Results of operations · EX-99.1 to Form 8-K
UnitedHealth Group Reports 2023 Results
Results of operations · EX-99.1 to Form 8-K
UnitedHealth Group Updates Business Outlook Ahead of Investor Conference
Regulation FD disclosure · EX-99.1 to Form 8-K
UnitedHealth Group to Host 2023 Investor Conference
Regulation FD disclosure · EX-99.1 to Form 8-K
UnitedHealth Group Reports Third Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
UnitedHealth Group Reports Second Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
UnitedHealth Group Reports First Quarter 2023 Results
Results of operations · EX-99.1 to Form 8-K
UnitedHealth Group Reports 2022 Results
Results of operations · EX-99.1 to Form 8-K
N E W S R E L E A S E
Regulation FD disclosure · EX-99.1 to Form 8-K
N E W S R E L E A S E
Regulation FD disclosure · EX-99.1 to Form 8-K
UnitedHealth Group Reports Third Quarter 2022 Results
Results of operations · EX-99.1 to Form 8-K
Optum and Change Healthcare Complete Combination
Regulation FD disclosure · EX-99.1 to Form 8-K
UnitedHealth Group Reports Second Quarter 2022 Results
Results of operations · EX-99.1 to Form 8-K
UnitedHealth Group Reports First Quarter 2022 Results
Results of operations · EX-99.1 to Form 8-K
CHANGE HEALTHCARE AND OPTUM EXTEND MERGER AGREEMENT
Regulation FD disclosure · EX-99.1 to Form 8-K
of March 28, 7 PM CT
Regulation FD disclosure · EX-99.1 to Form 8-K
N E W S R E L E A S E
Results of operations · EX-99.1 to Form 8-K
N E W S R E L E A S E
Regulation FD disclosure · EX-99.1 to Form 8-K
N E W S R E L E A S E
Regulation FD disclosure · EX-99.1 to Form 8-K
N E W S R E L E A S E
Results of operations · EX-99.1 to Form 8-K
N E W S R E L E A S E
Regulation FD disclosure · EX-99.1 to Form 8-K
N E W S R E L E A S E
Regulation FD disclosure · EX-99.1 to Form 8-K